{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-21-002176","form_type":"8-K","ticker":"FNCHQ","cik":"0001733257","company_name":"Finch Therapeutics Group, Inc.","filed_at":"2021-10-19T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.878211+00:00","generated_at":"2026-06-28T20:02:04.874128+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"low","headline":"Finch Therapeutics posts Jefferies IBD Summit slides; no new material disclosures","bullets":["Furnished slides under Item 7.01 for Jefferies Virtual Next Generation IBD Therapeutics Summit held October 2021.","Presentation titled 'Harnessing the Genomic Revolution & Machine Learning to Pioneer Microbiome Therapeutics'.","No financial results, guidance, or pipeline updates provided in the filing.","Slides available on company website under Events & Presentations."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-21-002176","json":"https://secwatch.observer/filing/0000950170-21-002176.json","markdown":"https://secwatch.observer/filing/0000950170-21-002176.md","text":"https://secwatch.observer/filing/0000950170-21-002176.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1733257/000095017021002176/0000950170-21-002176-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1733257/000095017021002176/fnch-20211019.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T20:02:04.874128+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}